article thumbnail

Opinion: Needed: a new framework to make sure health companies play fair with patient data

STAT

As a health policy wonk and health economist who has worked in pharmaceutical companies in the United States, Latin America, and Europe, I’ve seen vast volumes of data generated, gathered, aggregated, analyzed, shared, and resold by health care companies and organizations.

article thumbnail

Innoviva enters agreement to acquire La Jolla Pharmaceutical Company

Pharmaceutical Technology

Innoviva has signed a definitive merger agreement for the acquisition of all of the outstanding shares of La Jolla Pharmaceutical Company for $6.23 The post Innoviva enters agreement to acquire La Jolla Pharmaceutical Company appeared first on Pharmaceutical Technology.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA approves innovative monotherapy for treatment-resistant depression

European Pharmaceutical Review

Approval of this drug system for this indication is supported by positive clinical results demonstrating rapid improvement in depressive symptoms compared to placebo, according to the pharmaceutical company. At week 4, 22.5 percent of patients taking SPRAVATO achieved remission. This was compared to 7.6

article thumbnail

ECNP 2023: new esketamine NS safety data for depression

European Pharmaceutical Review

The Janssen Pharmaceutical Companies of Johnson & Johnson has revealed that according to new safety data, SPRAVATO ® (esketamine nasal spray [NS]) has demonstrated superior efficacy compared to quetiapine extended-release (Quetiapine XR) for treatment-resistant depression (TRD).

article thumbnail

The Definitive Guide to Evidence Generation

PharmaTech

This guide serves as a roadmap for pharmaceutical companies, researchers, healthcare professionals, and anyone interested in understanding the fundamentals of decentralized clinical trials.

article thumbnail

PDA revises report on glass container manufacturing

European Pharmaceutical Review

According the PDA, the standardised quality criteria in TR 43 are intended as a guidance overview for container manufacturers and for incoming container acceptance inspection at pharmaceutical companies. The post PDA revises report on glass container manufacturing appeared first on European Pharmaceutical Review.

article thumbnail

Getting Creative with Sustainability | How Pharma Engages

Pharma Marketing Network

The wave of interest in sustainability follows the value chain from top-tier pharmaceutical companies to their suppliers of every size. About 80% of pharmaceutical companies have announced a commitment to becoming carbon-neutral or made a net-zero pledge for carbon emissions. Where do most organizations start?